摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

phenacyl 4-methylphenylacetate | 639785-62-9

中文名称
——
中文别名
——
英文名称
phenacyl 4-methylphenylacetate
英文别名
Phenacyl 2-(4-methylphenyl)acetate
phenacyl 4-methylphenylacetate化学式
CAS
639785-62-9
化学式
C17H16O3
mdl
——
分子量
268.312
InChiKey
JOABSAFBFQNQSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    48-50 °C
  • 沸点:
    407.0±25.0 °C(Predicted)
  • 密度:
    1.144±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    phenacyl 4-methylphenylacetate氯磺酸 、 sodium hydride 作用下, 以 氯仿二甲基亚砜 为溶剂, 反应 4.0h, 生成 3-(5-Oxo-4-p-tolyl-2,5-dihydro-furan-3-yl)-benzenesulfonyl chloride
    参考文献:
    名称:
    设计和合成新型rofecoxib类似物作为潜在的环氧合酶(COX-2)抑制剂:用磺酰叠氮生物甾体替代甲基磺酰药效团
    摘要:
    A组罗非昔布类似物,具有sulfonylazide(SO 2 Ñ 3)取代基取代的磺酰(SO 2 CH 3)药效团在间位-位即3-(4-甲基,4-甲氧基或4-乙氧基苯基) -4-(3-磺酰基叠氮苯基)-2(5 H)呋喃酮(7a-c)和对位3-苯基-4-(4-磺酰基叠氮苯基)-2(5 H)呋喃酮(7d),3-(C–4苯环的4-氟或4-氯苯基)-4-(4-磺酰基叠氮苯基)-2(5 H)呋喃酮(7e-f)和4-(1-氧化-4-吡啶基)- 3-苯基-2(5 H设计并合成了呋喃酮(12)作为选择性环氧合酶2(COX-2)抑制剂进行评估。体外COX-1 / COX-2酶抑制研究表明3-苯基-4-(4-磺酰基叠氮苯基)-2(5 H)呋喃酮(7d)选择性抑制COX-1(COX-1 IC 50 = 0.6659μM; COX-2 IC 50 > 100μM)和3-(4-氟苯基)-4-(4-磺酰基叠氮苯基)-2(5
    DOI:
    10.1002/jhet.5570400518
  • 作为产物:
    描述:
    苯甲酰氯potassium tert-butylate 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 5.0h, 生成 phenacyl 4-methylphenylacetate
    参考文献:
    名称:
    由羧酸和叶立德亚砜无金属合成α-酰氧基酮
    摘要:
    描述了一种直接、无催化剂和无添加剂的方法,用于从 β-酮亚磺鎓叶立德和羧酸合成 α-酰氧基酮。使用硫叶立德和带有各种官能团的羧酸生产中等到高产率的α-酰氧基酮。最终,通过大规模反应并将合成的α-酰氧基酮衍生物转化为其他有价值的化合物,证明了该方法的适用性。
    DOI:
    10.1039/d3ob01683h
点击查看最新优质反应信息

文献信息

  • Metal-free synthesis of α-acyloxy ketones from carboxylic acids and sulfoxonium ylides
    作者:Naveen Kumar、Satyendra Kumar Pandey
    DOI:10.1039/d3ob01683h
    日期:——
    described for synthesizing α-acyloxy ketones from β-ketosulfoxonium ylides and carboxylic acids. Moderate to high yields of α-acyloxy ketones were produced using sulfoxonium ylides and carboxylic acids adorned with various functional groups. Eventually, the applicability of this approach has been shown via a large-scale reaction and transforming the synthesized α-acyloxy ketone derivatives into other valuable
    描述了一种直接、无催化剂和无添加剂的方法,用于从 β-酮亚磺鎓叶立德和羧酸合成 α-酰氧基酮。使用硫叶立德和带有各种官能团的羧酸生产中等到高产率的α-酰氧基酮。最终,通过大规模反应并将合成的α-酰氧基酮衍生物转化为其他有价值的化合物,证明了该方法的适用性。
  • BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES
    申请人:Alfa Instruments S.r.l.
    公开号:EP3692101B1
    公开(公告)日:2022-01-12
  • [EN] BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES<br/>[FR] DÉRIVÉS DE COLORANT BLEU BRILLANT (BBG) ET COMPOSITIONS DE COLORATION LES COMPRENANT POUR COLORER SÉLECTIVEMENT DES SUBSTRATS BIOLOGIQUES
    申请人:ALFA INSTR S R L
    公开号:WO2019068935A1
    公开(公告)日:2019-04-11
    The present invention relates to dye molecules and to staining compositions comprising said dye molecules that are particularly suitable for selectively staining biological substrates, such as structures in the posterior eye segment and proteins. Said dye molecules may be used in ophthalmic surgery to help the surgeon to visualize structures in the posterior eye structures as well as in protein assays to determine one or more analytical parameter of a protein. The dye molecules have the following structure (I) wherein X represents an organic or inorganic cation; and R1 represents a substituted or unsubstituted benzyl group. The present invention relates also to a new method for synthetizing dye molecules.
  • Design and synthesis of novel rofecoxib analogs as potential cyclooxygenase (COX-2) inhibitors: Replacement of the methylsulfonyl pharmacophore by a sulfonylazide bioisostere
    作者:Md. Jashim Uddin、P. N. Praveen Rao、Edward E. Knaus
    DOI:10.1002/jhet.5570400518
    日期:2003.9
    phenyl ring, and 4-(1-oxido-4-pyridyl)-3-phenyl-2(5H)furanone (12) were designed and synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. In vitro COX-1/COX-2 enzyme inhibition studies showed that 3-phenyl-4-(4-sulfonylazidophenyl)-2(5H)furanone (7d) inhibited COX-1 selectively (COX-1 IC50 = 0.6659 μM; COX-2 IC50 > 100 μM) and 3-(4-fluorophenyl)-4-(4-sulfonylazidophenyl)-2(5H)furanone
    A组罗非昔布类似物,具有sulfonylazide(SO 2 Ñ 3)取代基取代的磺酰(SO 2 CH 3)药效团在间位-位即3-(4-甲基,4-甲氧基或4-乙氧基苯基) -4-(3-磺酰基叠氮苯基)-2(5 H)呋喃酮(7a-c)和对位3-苯基-4-(4-磺酰基叠氮苯基)-2(5 H)呋喃酮(7d),3-(C–4苯环的4-氟或4-氯苯基)-4-(4-磺酰基叠氮苯基)-2(5 H)呋喃酮(7e-f)和4-(1-氧化-4-吡啶基)- 3-苯基-2(5 H设计并合成了呋喃酮(12)作为选择性环氧合酶2(COX-2)抑制剂进行评估。体外COX-1 / COX-2酶抑制研究表明3-苯基-4-(4-磺酰基叠氮苯基)-2(5 H)呋喃酮(7d)选择性抑制COX-1(COX-1 IC 50 = 0.6659μM; COX-2 IC 50 > 100μM)和3-(4-氟苯基)-4-(4-磺酰基叠氮苯基)-2(5
  • Construction of α-Acyloxy Ketones via Photoredox-Catalyzed O–H Insertion of Sulfoxonium Ylides with Carboxylic Acids
    作者:Qing Sun、Yuzhu Peng、Yujing Wang、Xiaoguang Bao
    DOI:10.1021/acs.orglett.3c02221
    日期:2023.9.15
    sulfoxonium ylides with carboxylic acids was advanced under mild and simple conditions, offering a practical approach for preparing α-acyloxy ketones with a broad scope of carboxylic acids. A combined experimental and computational study suggests that this reaction proceeds via a stepwise proton-assisted electron transfer mechanism.
    在此,在温和简单的条件下进行了光氧化还原催化的亚砜叶立德与羧酸的插入,为制备具有广泛羧酸的α-酰氧基酮提供了一种实用的方法。实验和计算相结合的研究表明,该反应通过逐步质子辅助电子转移机制进行。
查看更多